ALDOA Expression in Bladder Urothelial Carcinoma
ConditionBladder Urothelial Carcinoma
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorAssiut University
About this trial
1. Study the immunohistochemical expression of ALDOA in bladder urothelial cancer. 2. Correlate between ALDOA expression in specimens and different cilnicopathological factors. 3. Correlate between ALDOA expression and urothelial cancer prognosis and survival.
Eligibility criteria
Qualifiers
All cases diagnosed as bladder urothelial cancer with known follow-up data and presence of muscle proper detected in the specimens.
Disqualifiers
Subtypes of bladder cancer other than urothelial carcinoma subtype.
Cases of urothelial carcinoma without known follow up data.
Cases of urothelial carcinoma without muscle proper detected in the specimen.
Trial design
Treatments tested in this trial
- Immunohistochemistry
Treatment groups
No treatment groups listed
Locations
Sponsors and collaborators
Source ClinicalTrials.gov